A<sub>2A</sub> Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
The A<sub>2A</sub> adenosine receptor (A<sub>2A</sub>AR) is one of the four subtypes activated by nucleoside adenosine, and the molecules able to selectively counteract its action are attractive tools for neurodegenerative disorders. In order to find novel A<sub>2A</...
Main Authors: | Andrea Spinaci, Catia Lambertucci, Michela Buccioni, Diego Dal Ben, Claudia Graiff, Maria Cristina Barbalace, Silvana Hrelia, Cristina Angeloni, Seyed Khosrow Tayebati, Massimo Ubaldi, Alessio Masi, Karl-Norbert Klotz, Rosaria Volpini, Gabriella Marucci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/8/2386 |
Similar Items
-
A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01) -
Combined Therapy of A<sub>1</sub>AR Agonists and A<sub>2A</sub>AR Antagonists in Neuroinflammation
by: Gabriella Marucci, et al.
Published: (2021-02-01) -
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A<sub>2A</sub> Adenosine Receptor Useful in Neurodegenerative Disorders
by: Beatrice Francucci, et al.
Published: (2023-06-01) -
Adenosine Receptors as Neuroinflammation Modulators: Role of A<sub>1</sub> Agonists and A<sub>2A</sub> Antagonists
by: Aleix Martí Navia, et al.
Published: (2020-07-01) -
Design and Synthesis of new Naproxen Analogues as Potential Anti-inflammatory Agents
by: Noor H. Nasser, et al.
Published: (2018-03-01)